Efficacy of Walking Adaptability Training on Walking Capacity in Ambulatory People With Motor Incomplete Spinal Cord Injury: A Multicenter Pragmatic Randomized Controlled Trial.

People with incomplete spinal cord injury often struggle with balance and walking capacity, and rehabilitation teams have been exploring whether virtual-reality-based walking adaptability training on a treadmill offers an edge over standard locomotor and strength training. This trial compared six weeks of such training, delivered through a treadmill-based virtual reality system, against a similarly dosed program of conventional treadmill training plus lower-body strength exercises, in a small group of ambulatory adults with incomplete spinal cord injury across two centers. At follow-up, there was no statistically significant difference between the two groups in maximal walking speed, nor in secondary measures of functional ambulation, balance confidence, or participation. Interestingly, both groups improved over time regardless of which training they received.

The main limitation is the small sample, around forty participants split between two arms, which limits confidence that a true difference between approaches doesn't exist, even though this particular comparison showed none.

If you're living with an incomplete spinal cord injury and have some ability to walk, you may wonder whether newer, technology-based training, like walking practice in a virtual reality environment on a treadmill, works better than more traditional treadmill and strength training. This study looked at exactly that question. Researchers split a small group of participants into two groups for six weeks of training, matched for the same amount of time, one using the virtual reality treadmill system and the other doing conventional treadmill walking plus strength exercises.

Afterward, walking speed, how smoothly people handled everyday walking challenges, confidence in their balance, and participation in daily life had all improved somewhat over time in both groups, but the two training approaches did not differ from each other in any of these outcomes. This suggests that the fancier virtual reality approach wasn't found to produce better results than standard training in this study, though with only about forty people involved total, it's hard to be fully confident that a real difference truly doesn't exist. Larger studies would help clarify this.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This pragmatic multicenter randomized controlled trial addresses a specific clinical question: whether treadmill-based walking adaptability training delivered through a virtual reality system (the Gait Real-time Analysis Interactive Lab) offers any advantage over similarly dosed conventional locomotor and strength training for ambulatory people with motor incomplete spinal cord injury. Forty-one participants were randomized, seventeen to adaptability training and eighteen to conventional training, each receiving eleven hours of intervention over six weeks. The primary outcome, maximal walking speed measured via overground two-minute walk test, showed no statistically significant difference between groups at follow-up (mean difference -0.05 m/s, 95% CI -0.12 to 0.03).

Secondary outcomes, including the Spinal Cord Injury Functional Ambulation Profile, Activities-specific Balance Confidence scale, and participation restrictions on the Utrecht Scale, also showed no significant between-group differences. Notably, both groups demonstrated significant within-group improvement over time across these measures, but this improvement cannot be attributed to either intervention specifically given the absence of a non-exercise control arm. For clinical reasoning, this study informs equipment and resource decisions rather than treatment necessity: it does not establish that virtual reality-based adaptability training is superior to, or inferior to, standard treadmill and strength training, only that no statistically significant difference was detected in this trial.

The modest sample size limits confidence in ruling out a true difference, and the abstract does not report adverse events.